Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 673

1.

Steady-State Serum T3 Concentrations for 48 Hours Following the Oral Administration of a Single Dose of 3,5,3'-Triiodothyronine Sulfate (T3S).

Santini F, Giannetti M, Ricco I, Querci G, Saponati G, Bokor D, Rivolta G, Bussi S, Braverman LE, Vitti P, Pinchera A.

Endocr Pract. 2014 Jul;20(7):680-9. doi: 10.4158/EP13331.OR.

PMID:
24518178
2.

Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study.

Fast S, Hegedüs L, Pacini F, Pinchera A, Leung AM, Vaisman M, Reiners C, Wemeau JL, Huysmans DA, Harper W, Rachinsky I, de Souza HN, Castagna MG, Antonangeli L, Braverman LE, Corbo R, Düren C, Proust-Lemoine E, Marriott C, Driedger A, Grupe P, Watt T, Magner J, Purvis A, Graf H.

Thyroid. 2014 Apr;24(4):727-35. doi: 10.1089/thy.2013.0370. Epub 2014 Mar 4.

3.

The size of the community rather than its geographical location better defines the risk of iodine deficiency: results of an extensive survey in Southern Italy.

Aghini-Lombardi F, Vitti P, Antonangeli L, Fiore E, Piaggi P, Pallara A, Consiglio E, Pinchera A; Southern Italy Study Group for Iodine Deficiency Disorders.

J Endocrinol Invest. 2013 May;36(5):282-6.

PMID:
23712195
4.

Haptoglobin deficiency determines changes in adipocyte size and adipogenesis.

Gamucci O, Lisi S, Scabia G, Marchi M, Piaggi P, Duranti E, Virdis A, Pinchera A, Santini F, Maffei M.

Adipocyte. 2012 Jul 1;1(3):142-183.

5.

Frequency of the GPR7 Tyr135Phe allelic variant in lean and obese subjects.

Pelosini C, Maffei M, Ceccarini G, Marchi M, Marsili A, Galli G, Scartabelli G, Tamberi A, Latrofa F, Fierabracci P, Vitti P, Pinchera A, Santini F.

J Endocrinol Invest. 2013 Oct;36(9):712-5. doi: 10.3275/8929. Epub 2013 Apr 8.

PMID:
23563248
6.

Iodine fortification of vegetables improves human iodine nutrition: in vivo evidence for a new model of iodine prophylaxis.

Tonacchera M, Dimida A, De Servi M, Frigeri M, Ferrarini E, De Marco G, Grasso L, Agretti P, Piaggi P, Aghini-Lombardi F, Perata P, Pinchera A, Vitti P.

J Clin Endocrinol Metab. 2013 Apr;98(4):E694-7. doi: 10.1210/jc.2012-3509. Epub 2013 Mar 12.

PMID:
23482609
7.

The effect of voluntary iodine prophylaxis in a small rural community: the Pescopagano survey 15 years later.

Aghini Lombardi F, Fiore E, Tonacchera M, Antonangeli L, Rago T, Frigeri M, Provenzale AM, Montanelli L, Grasso L, Pinchera A, Vitti P.

J Clin Endocrinol Metab. 2013 Mar;98(3):1031-9. doi: 10.1210/jc.2012-2960. Epub 2013 Feb 22.

PMID:
23436921
8.

New echocardiographic techniques in the evaluation of left ventricular function in obesity.

Di Bello V, Fabiani I, Conte L, Barletta V, Delle Donne MG, Cuono C, Leo LA, Dini FL, Marzilli M, Pinchera A, Santini F.

Obesity (Silver Spring). 2013 May;21(5):881-92. doi: 10.1002/oby.20071. Review.

9.

Inverse relationship of food and alcohol intake to sleep measures in obesity.

Galli G, Piaggi P, Mattingly MS, de Jonge L, Courville AB, Pinchera A, Santini F, Csako G, Cizza G.

Nutr Diabetes. 2013 Jan 28;3:e58. doi: 10.1038/nutd.2012.33.

10.

Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series.

Ciampi R, Mian C, Fugazzola L, Cosci B, Romei C, Barollo S, Cirello V, Bottici V, Marconcini G, Rosa PM, Borrello MG, Basolo F, Ugolini C, Materazzi G, Pinchera A, Elisei R.

Thyroid. 2013 Jan;23(1):50-7. doi: 10.1089/thy.2012.0207. Epub 2012 Dec 16.

PMID:
23240926
11.

In vivo assessment about the effects of a diet containing iodine-enriched foodstuffs. A pilot study in 30 volunteers.

Frigeri M, Lercker G, Bonoli M, Fiore E, Tonacchera M, Pinchera A, Vitti P, Grasso L, Aghini-Lombardi F.

J Endocrinol Invest. 2013 Oct;36(9):667-71. doi: 10.3275/8769. Epub 2012 Nov 26.

PMID:
23211556
12.

Clinical characteristics and genetic analysis in women with premature ovarian insufficiency.

Ferrarini E, Russo L, Fruzzetti F, Agretti P, De Marco G, Dimida A, Gianetti E, Simoncini T, Simi P, Baldinotti F, Benelli E, Pucci E, Pinchera A, Vitti P, Tonacchera M.

Maturitas. 2013 Jan;74(1):61-7. doi: 10.1016/j.maturitas.2012.09.017. Epub 2012 Oct 26.

PMID:
23107817
13.

Thyroid volume and severity of Graves' orbitopathy.

Profilo MA, Sisti E, Marcocci C, Vitti P, Pinchera A, Nardi M, Rocchi R, Latrofa F, Menconi F, Altea MA, Leo M, Rago T, Marinò M.

Thyroid. 2013 Jan;23(1):97-102. doi: 10.1089/thy.2012.0379.

PMID:
23088654
14.

Rehabilitative orbital decompression for Graves' orbitopathy: risk factors influencing the new onset of diplopia in primary gaze, outcome, and patients' satisfaction.

Rocchi R, Lenzi R, Marinò M, Latrofa F, Nardi M, Piaggi P, Mazzi B, Altea MA, Pinchera A, Vitti P, Marcocci C, Sellari-Franceschini S.

Thyroid. 2012 Nov;22(11):1170-5. doi: 10.1089/thy.2012.0272. Epub 2012 Oct 16.

PMID:
23072549
15.

The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study.

Elisei R, Viola D, Torregrossa L, Giannini R, Romei C, Ugolini C, Molinaro E, Agate L, Biagini A, Lupi C, Valerio L, Materazzi G, Miccoli P, Piaggi P, Pinchera A, Vitti P, Basolo F.

J Clin Endocrinol Metab. 2012 Dec;97(12):4390-8. doi: 10.1210/jc.2012-1775. Epub 2012 Oct 12.

PMID:
23066120
16.

Enalapril reduces proliferation and hyaluronic acid release in orbital fibroblasts.

Botta R, Lisi S, Marcocci C, Sellari-Franceschini S, Rocchi R, Latrofa F, Menconi F, Altea MA, Leo M, Sisti E, Casini G, Nardi M, Pinchera A, Vitti P, Marinò M.

Thyroid. 2013 Jan;23(1):92-6. doi: 10.1089/thy.2012.0373.

PMID:
23030053
17.

Foreword.

Pinchera A.

J Endocrinol Invest. 2012;35(6 Suppl):1-2. No abstract available.

PMID:
23014066
18.

Thyroglobulin autoantibodies of patients with subacute thyroiditis are restricted to a major B cell epitope.

Latrofa F, Ricci D, Montanelli L, Altea MA, Pucci A, Pinchera A, Vitti P.

J Endocrinol Invest. 2012 Sep;35(8):712-4.

PMID:
23014133
19.

Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies.

Latrofa F, Ricci D, Montanelli L, Rocchi R, Piaggi P, Sisti E, Grasso L, Basolo F, Ugolini C, Pinchera A, Vitti P.

J Clin Endocrinol Metab. 2012 Nov;97(11):3974-82. doi: 10.1210/jc.2012-2406. Epub 2012 Sep 4.

PMID:
22948755
20.

Modifications in the papillary thyroid cancer gene profile over the last 15 years.

Romei C, Fugazzola L, Puxeddu E, Frasca F, Viola D, Muzza M, Moretti S, Nicolosi ML, Giani C, Cirello V, Avenia N, Rossi S, Vitti P, Pinchera A, Elisei R.

J Clin Endocrinol Metab. 2012 Sep;97(9):E1758-65. doi: 10.1210/jc.2012-1269. Epub 2012 Jun 28.

PMID:
22745248
21.

MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration.

Agretti P, Ferrarini E, Rago T, Candelieri A, De Marco G, Dimida A, Niccolai F, Molinaro A, Di Coscio G, Pinchera A, Vitti P, Tonacchera M.

Eur J Endocrinol. 2012 Sep;167(3):393-400. doi: 10.1530/EJE-12-0400. Epub 2012 Jun 22.

PMID:
22728346
22.

Prevalence of left ventricular hypertrophy and determinants of left ventricular mass in obese women.

Salvetti G, Pucci A, Fierabracci P, Ceccarini G, Palagi C, Delle Donne MG, Di Bello V, Piaggi P, Vitti P, Salvetti A, Pinchera A, Santini F.

High Blood Press Cardiovasc Prev. 2012 Mar 1;19(1):33-9. doi: 10.2165/11593700-000000000-00000.

PMID:
22670585
23.

Serum insulin-like growth factor-1 concentrations are reduced in severely obese women and raise after weight loss induced by laparoscopic adjustable gastric banding.

Galli G, Pinchera A, Piaggi P, Fierabracci P, Giannetti M, Querci G, Scartabelli G, Manetti L, Ceccarini G, Martinelli S, Di Salvo C, Anselmino M, Bogazzi F, Landi A, Vitti P, Maffei M, Santini F.

Obes Surg. 2012 Aug;22(8):1276-80. doi: 10.1007/s11695-012-0669-1.

PMID:
22648796
24.

Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.

Latrofa F, Ricci D, Montanelli L, Rocchi R, Piaggi P, Sisti E, Grasso L, Basolo F, Ugolini C, Pinchera A, Vitti P.

J Clin Endocrinol Metab. 2012 Jul;97(7):2380-7. doi: 10.1210/jc.2011-2812. Epub 2012 Apr 26.

PMID:
22539585
25.

Salivary glands ultrasound examination after radioiodine-131 treatment for differentiated thyroid cancer.

Brozzi F, Rago T, Bencivelli W, Bianchi F, Santini P, Vitti P, Pinchera A, Ceccarelli C.

J Endocrinol Invest. 2013 Mar;36(3):153-6. doi: 10.3275/8335. Epub 2012 Apr 5.

PMID:
22522602
26.

Advances in the follow-up of differentiated or medullary thyroid cancer.

Elisei R, Pinchera A.

Nat Rev Endocrinol. 2012 Apr 3;8(8):466-75. doi: 10.1038/nrendo.2012.38. Review.

PMID:
22473335
27.

Metabolic engineering of the iodine content in Arabidopsis.

Landini M, Gonzali S, Kiferle C, Tonacchera M, Agretti P, Dimida A, Vitti P, Alpi A, Pinchera A, Perata P.

Sci Rep. 2012;2:338. doi: 10.1038/srep00338. Epub 2012 Mar 27.

28.

Low prevalence of the somatic M918T RET mutation in micro-medullary thyroid cancer.

Romei C, Ugolini C, Cosci B, Torregrossa L, Vivaldi A, Ciampi R, Tacito A, Basolo F, Materazzi G, Miccoli P, Vitti P, Pinchera A, Elisei R.

Thyroid. 2012 May;22(5):476-81. doi: 10.1089/thy.2011.0358. Epub 2012 Mar 9.

PMID:
22404432
29.

Sporadic congenital nonautoimmune hyperthyroidism caused by P639S mutation in thyrotropin receptor gene.

Agretti P, De Marco G, Biagioni M, Iannilli A, Marigliano M, Pinchera A, Vitti P, Cherubini V, Tonacchera M.

Eur J Pediatr. 2012 Jul;171(7):1133-7. doi: 10.1007/s00431-012-1702-z. Epub 2012 Feb 28.

PMID:
22371259
30.

Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line.

Vivaldi A, Ciampi R, Tacito A, Molinaro E, Agate L, Bottici V, Pinchera A, Collecchi P, Elisei R.

Mol Cell Endocrinol. 2012 May 15;355(1):41-8. doi: 10.1016/j.mce.2012.01.015. Epub 2012 Jan 25.

PMID:
22305971
31.

The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center.

Elisei R, Romei C, Renzini G, Bottici V, Cosci B, Molinaro E, Agate L, Cappagli V, Miccoli P, Berti P, Faviana P, Ugolini C, Basolo F, Vitti P, Pinchera A.

J Clin Endocrinol Metab. 2012 Feb;97(2):426-35. doi: 10.1210/jc.2011-2046. Epub 2011 Dec 7.

PMID:
22162466
32.

Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric banding.

Giannetti M, Piaggi P, Ceccarini G, Mazzeo S, Querci G, Fierabracci P, Salvetti G, Galli G, Ricco I, Martinelli S, Di Salvo C, Anselmino M, Landi A, Vitti P, Pinchera A, Santini F.

Int J Obes (Lond). 2012 Mar;36(3):336-41. doi: 10.1038/ijo.2011.243. Epub 2011 Dec 6.

PMID:
22143620
33.

Outcome of Graves' orbitopathy after total thyroid ablation and glucocorticoid treatment: follow-up of a randomized clinical trial.

Leo M, Marcocci C, Pinchera A, Nardi M, Megna L, Rocchi R, Latrofa F, Altea MA, Mazzi B, Sisti E, Profilo MA, Marinò M.

J Clin Endocrinol Metab. 2012 Jan;97(1):E44-8. doi: 10.1210/jc.2011-2077. Epub 2011 Oct 26.

PMID:
22031515
34.

Genetic markers to discriminate benign and malignant thyroid nodules with undetermined cytology in an area of borderline iodine deficiency.

Tonacchera M, Agretti P, Rago T, De Marco G, Niccolai F, Molinaro A, Scutari M, Candelieri A, Conforti D, Musmanno R, Di Coscio G, Basolo F, Iacconi P, Miccoli P, Pinchera A, Vitti P.

J Endocrinol Invest. 2012 Sep;35(8):754-9. Epub 2011 Oct 4.

PMID:
21979329
35.

Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling.

Cetani F, Saponaro F, Banti C, Cianferotti L, Vignali E, Chiavistelli S, Viccica G, Pinchera A, Marcocci C.

J Endocrinol Invest. 2012 Jul;35(7):655-60. doi: 10.3275/7970. Epub 2011 Sep 30.

PMID:
21971564
36.

Human leptin tissue distribution, but not weight loss-dependent change in expression, is associated with methylation of its promoter.

Marchi M, Lisi S, Curcio M, Barbuti S, Piaggi P, Ceccarini G, Nannipieri M, Anselmino M, Di Salvo C, Vitti P, Pinchera A, Santini F, Maffei M.

Epigenetics. 2011 Oct 1;6(10):1198-206. doi: 10.4161/epi.6.10.16600. Epub 2011 Oct 1.

37.

Obesity-associated hepatosteatosis and impairment of glucose homeostasis are attenuated by haptoglobin deficiency.

Lisi S, Gamucci O, Vottari T, Scabia G, Funicello M, Marchi M, Galli G, Arisi I, Brandi R, D'Onofrio M, Pinchera A, Santini F, Maffei M.

Diabetes. 2011 Oct;60(10):2496-505. doi: 10.2337/db10-1536. Epub 2011 Aug 26.

38.

Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma.

Ciampi R, Romei C, Cosci B, Vivaldi A, Bottici V, Renzini G, Ugolini C, Tacito A, Basolo F, Pinchera A, Elisei R.

Mol Cell Endocrinol. 2012 Jan 2;348(1):176-82. doi: 10.1016/j.mce.2011.08.004. Epub 2011 Aug 16.

PMID:
21867742
39.

In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer.

Cosci B, Vivaldi A, Romei C, Gemignani F, Landi S, Ciampi R, Tacito A, Molinaro E, Agate L, Bottici V, Cappagli V, Viola D, Piaggi P, Vitti P, Pinchera A, Elisei R.

Endocr Relat Cancer. 2011 Sep 20;18(5):603-12. doi: 10.1530/ERC-11-0117. Print 2011 Oct.

PMID:
21810974
40.

Description of an AGPAT2 pathologic allelic variant in a 54-year-old Caucasian woman with Berardinelli-Seip syndrome.

Pelosini C, Martinelli S, Bagattini B, Pucci E, Fierabracci P, Scartabelli G, Salvetti G, Vitti P, Maffei M, Pinchera A, Santini F.

Acta Diabetol. 2011 Sep;48(3):243-6. doi: 10.1007/s00592-011-0308-7. Epub 2011 Jul 9.

PMID:
21744063
41.

Vascular generation of tumor necrosis factor-α reduces nitric oxide availability in small arteries from visceral fat of obese patients.

Virdis A, Santini F, Colucci R, Duranti E, Salvetti G, Rugani I, Segnani C, Anselmino M, Bernardini N, Blandizzi C, Salvetti A, Pinchera A, Taddei S.

J Am Coll Cardiol. 2011 Jul 12;58(3):238-47. doi: 10.1016/j.jacc.2011.01.050.

42.

Thyroid-stimulating hormone levels in the first days of life and perinatal factors associated with sub-optimal neuromotor outcome in pre-term infants.

Belcari F, Placidi G, Guzzetta A, Tonacchera M, Ciampi M, Bartoli A, Scaramuzzo RT, Frumento P, Cioni G, Pinchera A, Boldrini A, Ghirri P.

J Endocrinol Invest. 2011 Nov;34(10):e308-13. doi: 10.3275/7795. Epub 2011 Jun 7.

PMID:
21659794
43.

Performance evaluation of the Vitros(®)3600 immunodiagnostic system for the determination of free thyroid hormones.

Querci G, Galli G, Piaggi P, Rosellini V, Giannetti M, Luchetti F, Donadio C, Tognotti D, Caravelli P, Vitti P, Grasso L, Pinchera A, Santini F.

Clin Chem Lab Med. 2011 Aug;49(8):1385-7. doi: 10.1515/CCLM.2011.616. Epub 2011 May 28. No abstract available.

PMID:
21619476
44.

Radioiodine 131I treatment for large nodular goiter: recombinant human thyrotropin allows the reduction of radioiodine 131I activity to be administered in patients with low uptake.

Ceccarelli C, Antonangeli L, Brozzi F, Bianchi F, Tonacchera M, Santini P, Mazzeo S, Bencivelli W, Pinchera A, Vitti P.

Thyroid. 2011 Jul;21(7):759-64. doi: 10.1089/thy.2010.0088. Epub 2011 May 13.

PMID:
21568727
45.

Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine.

Fiore E, Rago T, Latrofa F, Provenzale MA, Piaggi P, Delitala A, Scutari M, Basolo F, Di Coscio G, Grasso L, Pinchera A, Vitti P.

Endocr Relat Cancer. 2011 Jul 1;18(4):429-37. doi: 10.1530/ERC-11-002. Print 2011 Aug.

PMID:
21565972
46.

Identification and functional analysis of novel dual oxidase 2 (DUOX2) mutations in children with congenital or subclinical hypothyroidism.

De Marco G, Agretti P, Montanelli L, Di Cosmo C, Bagattini B, De Servi M, Ferrarini E, Dimida A, Freitas Ferreira AC, Molinaro A, Ceccarelli C, Brozzi F, Pinchera A, Vitti P, Tonacchera M.

J Clin Endocrinol Metab. 2011 Aug;96(8):E1335-9. doi: 10.1210/jc.2010-2467. Epub 2011 May 11.

PMID:
21565790
47.

Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma.

Cancemi L, Romei C, Bertocchi S, Tarrini G, Spitaleri I, Cipollini M, Landi D, Garritano S, Pellegrini G, Cristaudo A, Pinchera A, Barale R, Elisei R, Landi S, Gemignani F.

Int J Cancer. 2011 Dec 15;129(12):2816-24. doi: 10.1002/ijc.25937. Epub 2011 Apr 25.

48.

3-Iodothyronamine metabolism and functional effects in FRTL5 thyroid cells.

Agretti P, De Marco G, Russo L, Saba A, Raffaelli A, Marchini M, Chiellini G, Grasso L, Pinchera A, Vitti P, Scanlan TS, Zucchi R, Tonacchera M.

J Mol Endocrinol. 2011 Jul 12;47(1):23-32. doi: 10.1530/JME-10-0168. Print 2011 Aug.

PMID:
21511808
49.

Hyperthyroidism and pregnancy. An Italian Thyroid Association (AIT) and Italian Association of Clinical Endocrinologists (AME) joint statement for clinical practice.

Negro R, Beck-Peccoz P, Chiovato L, Garofalo P, Guglielmi R, Papini E, Tonacchera M, Vermiglio F, Vitti P, Zini M, Pinchera A.

J Endocrinol Invest. 2011 Mar;34(3):225-31. doi: 10.3275/7619. Epub 2011 Mar 22. No abstract available.

PMID:
21427528
50.

Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study.

Graf H, Fast S, Pacini F, Pinchera A, Leung A, Vaisman M, Reiners C, Wemeau JL, Huysmans D, Harper W, Driedger A, de Souza HN, Castagna MG, Antonangeli L, Braverman L, Corbo R, Düren C, Proust-Lemoine E, Edelbroek MA, Marriott C, Rachinsky I, Grupe P, Watt T, Magner J, Hegedus L.

J Clin Endocrinol Metab. 2011 May;96(5):1368-76. doi: 10.1210/jc.2010-1193. Epub 2011 Feb 23.

PMID:
21346067

Supplemental Content

Loading ...
Support Center